<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53729">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01991431</url>
  </required_header>
  <id_info>
    <org_study_id>U1111-1149-9900</org_study_id>
    <nct_id>NCT01991431</nct_id>
  </id_info>
  <brief_title>ROUTE Registry Of the Utilisation of the Transaortic (Tao) TAVI Approach Using the Edwards Sapien XT Valve</brief_title>
  <acronym>ROUTE</acronym>
  <official_title>Registry Of the Utilisation of the Transaortic (Tao) TAVI Approach Using the Edwards Sapien XT Valve</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut für Pharmakologie und Präventive Medizin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut für Pharmakologie und Präventive Medizin</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an international multi-center, prospective, observational registry with consecutive
      patient enrollment intended to determine outcome Parameters within 30 days after transaortic
      transcatheter aortic valve replacement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this registry is to expand upon existing data sets, to identify patient
      characteristics and indicators related to complications and clinical benefits for patients
      with symptomatic severe calcific degenerative aortic stenosis that are undergoing
      transaortic transcatheter procedure with the commercially available Edwards SAPIEN XT
      Transcatheter Heart Valve with the Ascendra+ System.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>30 Days</target_duration>
  <primary_outcome>
    <measure>Overall mortality</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>to determine Overall mortality within 30 days after TAVI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TAVI-related in-Hospital and 30 d mortality</measure>
    <time_frame>30 days after TAVI</time_frame>
    <safety_issue>No</safety_issue>
    <description>see title</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication rates</measure>
    <time_frame>30 days after TAVI</time_frame>
    <safety_issue>No</safety_issue>
    <description>Complication rates as to VARC2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients with adverse Events in Relation to Baseline Parameters</measure>
    <time_frame>30 days after TAVI</time_frame>
    <safety_issue>No</safety_issue>
    <description>Identify multivariable adjusted predictors for adverse outcomes of transaortic TAVI</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>TAVI</arm_group_label>
    <description>All Patients undergoing transaortic transcatheter valve implantation with commercially available Edwards SAPIEN XT Transcatheter Heart Valve with the Ascendra+ Delivery-System in participating sites</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All Patients undergoing transaortic transcatheter valve implantation with commercially
        available Edwards SAPIEN XT Transcatheter Heart Valve with the Ascendra+ Delivery-System
        in participating sites
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Intended transaortic (Tao) TAVI using Edwards SAPIEN XT Transcatheter Heart Valve
             with the Ascendra+ Delivery-System

          -  Compliance with the indications according to the Instructions for Use

          -  Written informed consent

        Exclusion Criteria:

          -  Presence of contraindications as to the Instructions for Use

          -  TAo with concomitant procedure (e.g. Tao + CABG)

          -  Participation in the SOURCE XT registry
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vinayak Bapat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Thomas' Hospital, London, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mauro Romano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Hospitalier Jacques Cartier, Massy, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kerstin Plate</last_name>
    <phone>+4944718503331</phone>
    <email>kp@route-registry.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peter Bramlage</last_name>
    <phone>+4944718503339</phone>
    <email>peter.bramlage@ippmed.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cardiac Surgery dpt., Innsbruck Medical University Hospital</name>
      <address>
        <city>Innsbruck</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nikolaos Bonaros, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Division of Cardiology, Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mika Laine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH J. Minjoz - Besancon</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sidney Chocron, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Sydney Chocron, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Louis Labrousse, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Louis Labrousse, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Cardio-Vasculaire et Pneumologie Louis Pradel</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Olivier Jegaden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Jacques Cartier Massy</name>
      <address>
        <city>Massy</city>
        <zip>91349</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauro Romano, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Mauro Romano, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Yves Litzler, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Pierre-Yves Litzler, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rangueil - Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bertrand Marcheix, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Bertrand Marcheix, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Robert-Bosch-Hospital Stuttgart</name>
      <address>
        <city>Stuttgart</city>
        <state>Baden-Württemberg</state>
        <zip>70376</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hardy Baumbach, Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Hardy Baumbach, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städt. Klinikum München GmbH Herzchirurgie Bogenhausen</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>81925</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Walter Eichinger, Prof. Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Walter Eichinger, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lieber, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westdeutsches Herzzentrum Essen - Uniklinikum -</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Thielmann, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>M. Thielmann, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Kiel - Kardiologie u. Angiologie</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig-Holstein</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derk Frank, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Derk Frank, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Univ. Padova, Azienda Ospedaliera di Padova</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gino Gerosa, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Guiseppe Feltrin, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gino Gerosa, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico San Matteo/Department of Cardiac Surgery</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marco Aiello, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Riccardo Cocchieri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rikshospital Oslo</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kjell A. Rein, md</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinika Kardiochirurgii UCK Gdansk</name>
      <address>
        <city>Gdansk</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>G. Jagielak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Thomas Hospital Cardiothoracic surgery dept</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vinayat Bapat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>James Cook Hospital - Cardiothoracic Division</name>
      <address>
        <city>Middlesborough</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andrew Owens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.route-registry.com</url>
  </link>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 29, 2014</lastchanged_date>
  <firstreceived_date>November 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
